Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
12/31/2009 | US20090326196 Proteins Containing a Fluorinated Amino Acid, and Methods of Using Same |
12/31/2009 | US20090326195 Process for the manufacture of peptides |
12/31/2009 | US20090326193 Stabilizing alkylglycoside compositions and methods thereof |
12/31/2009 | US20090325887 Peptides and regulation of calcium channels |
12/31/2009 | US20090325884 Method for Detecting Autoantibodies Formed in Rheumatoid Arthritis |
12/31/2009 | US20090325869 Synthetic regulators of ferritin protein nanocage pores and methods of use thereof |
12/31/2009 | US20090325314 N-Methyl Scanning Mutagenesis |
12/31/2009 | US20090325168 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples |
12/31/2009 | US20090324707 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines |
12/31/2009 | US20090324635 Caspofungin free of caspofungin impurity A |
12/31/2009 | US20090324633 Immunogens from Uropathogenic Escherichia Coli |
12/31/2009 | US20090324632 Methods and reagents for vaccination which generate a CD8 T cell immune response |
12/31/2009 | US20090324620 Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
12/31/2009 | US20090324495 Compounds and methods for enzyme-mediated tumor imaging and therapy |
12/30/2009 | WO2009158034A1 Caspofungin free of caspofungin impurity a |
12/30/2009 | WO2009156541A1 Fluorescent sensor and use thereof for detection of cyclin-dependent kinase inhibitors and/or for detection of cyclins |
12/30/2009 | WO2009134382A3 Cyclopeptides containing rgd mimetics as imaging markers for integrins |
12/30/2009 | WO2009127072A8 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use |
12/30/2009 | WO2009059011A9 Hla-dr binding peptides and their uses |
12/30/2009 | EP2138507A1 Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles |
12/30/2009 | EP2138195A2 IFBM's to promote attachment of target analytes |
12/30/2009 | EP2137209A1 Compounds for the diagnosis of diseases associated with vcam expression |
12/30/2009 | EP2137208A2 Compounds for diagnosing apoptosis |
12/30/2009 | EP2136831A2 Anti-angiogenic peptides |
12/30/2009 | EP1618380B1 N epsilon AND/OR N alpha DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH (M(OH2)3(CO)3)+ BY FAC COORDINATION |
12/30/2009 | EP1409482B1 Dye-sulfenates for dual phototherapy |
12/30/2009 | EP0804561B1 Regulated transcription of targeted genes and other biological events |
12/30/2009 | CN101616928A Novel macromolecule transduction domains and methods for identification and uses thereof |
12/30/2009 | CN101613395A Improved gene construction method and property testing of fast-acting insulin precursor |
12/29/2009 | US7638599 Enhance uptake of a pharmaceutically active agent into a cell, into or out of an intracellular compartment, and across a cell layer either directly or from a pharmaceutically active agent loaded particle; drug delivery |
12/29/2009 | US7638495 inhibiting precipitation; bone morphogenic proteins |
12/29/2009 | US7638494 G-type peptides to ameliorate atherosclerosis |
12/29/2009 | CA2282720C Dolastatin-15 derivatives in combination with taxanes |
12/24/2009 | US20090318667 Peptoid compositions and methods of using the same |
12/24/2009 | US20090318665 Pharmaceutical formulations |
12/24/2009 | US20090318366 Cholesterol lowering protein hydrolysates |
12/24/2009 | US20090318365 Metastin derivatives and use thereof |
12/24/2009 | US20090318364 Method and peptide for regulating cellular activity |
12/24/2009 | US20090318347 Novel compounds and their effects on feeding behaviour |
12/24/2009 | US20090318336 Deuterated Cyclosporine Analogs and Methods of Making the Same |
12/24/2009 | US20090318335 Heterodimeric Peptide Compounds Displaying Ngf Activity and Their Use to Treat Neurodegenerative Disorders |
12/24/2009 | US20090317428 Immunogenic T-Helper Epitopes From Human Tumour Antigens and Immunotherapeutic Methods Using Said Epitopes |
12/24/2009 | US20090317419 Tetramers |
12/24/2009 | US20090317418 Vaccines and methods for prevention and treatment of drug-resistant hiv-1 and hepatitis b virus |
12/24/2009 | US20090317414 Cancer vaccine comprising a mucin 1 (muc1) t cell epitope-derived peptide |
12/24/2009 | US20090317395 Antimicrobial Peptide Derived from Galanin Message Associated Peptide (GMAP) |
12/24/2009 | US20090317379 Autophilic antibodies and method of making the same |
12/24/2009 | US20090317326 Radiofluorination methods |
12/23/2009 | WO2009155556A2 Crkl targeting peptides |
12/23/2009 | WO2009155366A2 Improved peptide mediators of cholesterol efflux |
12/23/2009 | WO2009154330A1 An synthetic peptide containing bone forming peptide 2(bfp 2) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide |
12/23/2009 | WO2009154264A1 Peptide |
12/23/2009 | WO2009153992A1 Cdca1 epitope peptides and vaccines containing the same |
12/23/2009 | WO2009153418A1 Harp peptides inhibiting tumour growth |
12/23/2009 | WO2009153294A1 Use of a tpb salt for the separation of biomolecules |
12/23/2009 | WO2009153029A1 Anti-prion protein antibody fragment |
12/23/2009 | WO2009152850A1 Peptide manufacturing process |
12/23/2009 | EP2135880A1 Anti-prion protein antibody fragment |
12/23/2009 | EP2135875A1 Methods for the specific production of lysobactin derivatives |
12/23/2009 | EP2134367A2 Integrated photoactive peptides and uses thereof |
12/23/2009 | CN101607985A Monoclonal antibody for anti-human CEA, a composition containing same and application thereof |
12/23/2009 | CN101607984A Multi-copy polypeptide and application thereof |
12/23/2009 | CN101607983A Encephalitis B virus PrM/M protein B cell antigen epitope polypeptide and applications |
12/23/2009 | CN101607982A Fish skin collagen peptide with whitening effect and preparation process and application thereof |
12/23/2009 | CN101607913A 改进的螯合剂缀合物 Improved chelator conjugate |
12/23/2009 | CN100572390C Inhibitor of stem cell proliferation and uses thereof |
12/23/2009 | CN100572389C BIM apoptosis effect minimum core sequence and its preparation and uses |
12/23/2009 | CA2728763A1 Crkl targeting peptides |
12/23/2009 | CA2728268A1 Cdca1 epitope peptides and vaccines containing the same |
12/23/2009 | CA2727909A1 Anti-prion protein antibody fragment |
12/23/2009 | CA2727693A1 Use of a tpb salt for the separation of biomolecules |
12/23/2009 | CA2727465A1 Improved peptide mediators of cholesterol efflux |
12/22/2009 | US7635751 For development of pharmaceutical preparations such as neutral nerve function regulator, circulatory function regulator, a cardiac function regulator, an immune function regulator, a digestive organ function regulator, metabolic function regulator |
12/22/2009 | US7635749 Methods and compositions for prolonging elimination half-times of bioactive compounds |
12/22/2009 | US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
12/22/2009 | CA2376763C Process for preparing lh-rh derivatives |
12/22/2009 | CA2276267C Peptide-lipid conjugates, liposomes and liposomal drug delivery |
12/17/2009 | WO2009152519A2 Novel antiviral peptides against influenza virus |
12/17/2009 | WO2009151520A2 Biocompatible and biodegradable elastomeric polymers |
12/17/2009 | WO2009151383A1 Melanocortin receptor-specific peptides for the treatment of obesity and other diseases associated with melanocortin receptor function |
12/17/2009 | WO2009151341A1 Process for preparing caspofungin and intermediates thereof |
12/17/2009 | WO2009151313A1 A novel antiviral peptide against avian influenza virus h9n2 |
12/17/2009 | WO2009150835A1 Iqgap3 epitope peptides and vaccines containing the same |
12/17/2009 | WO2009150822A1 Mybl2 epitope peptides and vaccines containing the same |
12/17/2009 | WO2009150657A1 Improved process for preparation of eptifibatide by fmoc solid phase synthesis |
12/17/2009 | WO2009149562A1 Compositions and methods for modulating nicotinic/nmda receptor function |
12/17/2009 | WO2009149554A1 Antimicrobial components of the mucus and extruded slime of hagfish (myxine glutinosa) |
12/17/2009 | WO2009087467A3 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
12/17/2009 | WO2006006195A9 Antibacterial peptides and analogues thereof |
12/17/2009 | US20090312521 Antibiotic drosocin derivatives |
12/17/2009 | US20090312266 Peptide derived from vascular endothelial growth factor receptor-1 binding integrin alpha5beta1 having proangiogenic activity |
12/17/2009 | US20090312265 Novel antimicrobial peptides and use thereof |
12/17/2009 | US20090312264 Squamous Cell Carcinoma Antigen-Derived Peptide Binding to HLA-A24 Molecule |
12/17/2009 | US20090312260 Drug therapy for celiac sprue |
12/17/2009 | US20090312248 Antimicrobial protein |
12/17/2009 | US20090311283 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
12/17/2009 | US20090311282 Neutralizing gdf8 epitope-based growth enhancing vaccine |
12/17/2009 | US20090311280 Novel tnf receptor regulatory domain |
12/17/2009 | US20090311279 Colorectal Cancer Antigen |
12/17/2009 | US20090311184 High penetration prodrug compositions of peptides and peptide-related compounds |